Research Empowers, Co‑Creating the Future | JibaiChuan and the Zhejiang Central Laboratory Sign a Strategic Industry‑Academia‑Research Partnership!


Release date:

2023-11-30

To further explore “The innovative path of high-quality development in Chinese medicinal materials—‘planting lingzhi under the red yew tree’”—on November 28, Ji Baichuan attended. Jinhua Research Institute of Zhejiang University of Traditional Chinese Medicine held At the “Zhejiang Central Laboratory’s Mass Signing Ceremony for Industry–Research Collaboration and Industry–Academia Integration Academic Salon,” Bao Jiajin, Chairman of Zhejiang JibaiChuan Pharmaceutical Co., Ltd., signed a strategic cooperation agreement with the Zhejiang Central Laboratory and jointly unveiled the plaque.

 

Wen Chengping, Vice President of Zhejiang University of Traditional Chinese Medicine, member of the Party Committee, and Director of the Jinhua Research Institute; Chen Su, Party Secretary and Director of the Jinhua Municipal Science and Technology Bureau; Lu Saihua, Second-Level Inspector of the Jinhua Municipal Administration for Market Regulation; Pan Ganggang, Deputy District Mayor of Jindong District; Cao Jin, Director of the Jindong District Science and Technology Bureau; Ying Huaguan, Party Secretary of the Jinhua Municipal Institute for Food and Drug Inspection and Testing, and Zhu Zhongju, its Director; as well as Wu Xiaoming, President and Deputy Secretary of the Party Committee of the Jinhua People’s Hospital, attended the ceremony and witnessed the signing.

 

At the meeting, leaders from various units delivered speeches, emphasizing that… The goal of revitalizing high-quality Zhejiang‑produced medicines and promoting the Zhejiang school of traditional Chinese medicine explicitly calls for leveraging Jinhua City’s local strengths, accelerating two-way empowerment and integrated development, and exploring the joint establishment of a high‑standard market regulatory system to ensure the sound development of TCM and its related industries.

 

At a specialized academic lecture on industry–university–research collaboration hosted by the Jinhua Research Institute, Cao Guodong, Deputy General Manager of Zhejiang JibaiChuan Pharmaceutical Co., Ltd., delivered a presentation titled “Symbiosis Between Medicinal Plants and Forests: Pursuing Both Quality and Efficacy—JibaiChuan’s Exploration.” The keynote report, “An Innovative Path for the High-Quality Development of Chinese Medicinal Materials: ‘Cultivating Ganoderma lucidum Under Taxus chinensis,’” provides a detailed exposition on the wild‑adaptation cultivation and ecological processing of Ganoderma lucidum, while also identifying the challenges, bottlenecks, and difficulties encountered during the cultivation process.

 

The report points out that lingzhi can only maintain its proper qualities when it returns to the forest understory. “Spiritual Essence”: Ji Baichuan cultivates lingzhi mushrooms beneath yew trees, infusing the lingzhi spore powder with the remarkable properties of paclitaxel found in the yews, thereby fostering a symbiotic relationship between the lingzhi and the yew forest. During its growth, the lingzhi benefits from the nourishment of sunlight and rainfall, as well as the life‑giving support of the surrounding trees and soil. As a result, the wild‑crafted lingzhi spore powder—grown under the yew canopy—contains over 300 unique molecular constituents, with virtually no detectable pesticide residues or harmful heavy metals, and boasts a natural fungal aroma that is neither bitter nor sour, making it ready to be savored just as it is.

 

Looking ahead, JibaiChuan will seize this opportunity to launch research‑and‑development collaborations with the Zhejiang Central Laboratory on Ganoderma lucidum spore powder. Upholding tradition without being bound by the past and innovating while staying true to its roots, the company will further strengthen communication and cooperation, accelerate the translation of research findings into practical applications, and ensure the successful implementation of all collaborative projects outlined in the strategic agreement. Through such efforts, JibaiChuan aims to achieve mutually beneficial outcomes, jointly advancing the high‑quality development of Zhejiang’s traditional Chinese medicine sector and industry.